Physician

James M. Coghill, M.D.

According to 2025 Medicare claims, James Coghill, M.D. (NPI: 1801000880) practices hematopoietic cell transplantation and cellular therapy in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (NPI: 1780669200; TIN: 561732213) and primary practice location at 27514-4220.

Coghill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 56 traditional Medicare patients, billed 376 HCPCS/CPT codes, and received $26,026 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 341 prescription claims across 30 beneficiaries totaling $1,100,208 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2023 DME data shows 24 claims. Open Payments data shows 1 records totaling $53,597. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $15,301 to $26,026. Similarly, Part D prescription costs have moved sharply higher in recent years, from $56,911 to $1,100,208. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	53	203	$15,301
2016	48	244	$17,443
2017	51	231	$17,890
2018	30	135	$10,125
2019	64	269	$22,588
2020	62	321	$28,412
2021	89	521	$44,830
2022	76	446	$37,369
2023	61	242	$20,500
2024	56	376	$26,026

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	125	$56,911
2016	N/R	144	$63,472
2017	14	149	$105,036
2018	N/R	106	$84,872
2019	16	141	$184,430
2020	18	198	$333,330
2021	25	206	$299,601
2022	32	333	$637,524
2023	27	405	$1,043,480
2024	30	341	$1,100,208

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	24	$490
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	14	14	$121
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	31	93	$98
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	23	119	$88
99239	Hospital discharge day management, more than 30 minutes	16	17	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	29	72	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	51	1,530	$842,389
Valacyclovir	Valacyclovir Hcl	37	2,587	$2,791
Budesonide Dr	Budesonide	11	330	$561
Prednisone	Prednisone	31	1,050	$188
Pantoprazole Sodium	Pantoprazole Sodium	16	840	$96

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$53,597	SANOFI US SERVICES INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James M. Coghill, M.D.?

Tedicare shows public-source Medicare data for James M. Coghill, M.D. (NPI 1801000880), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James M. Coghill, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James M. Coghill, M.D.?

James M. Coghill, M.D. is linked to UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (billing NPI 1780669200) in the available physician profile data.

Does James M. Coghill, M.D. have Open Payments data?

James M. Coghill, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.